Given the ongoing pandemic, the 28th Conference on Retroviruses and Opportunistic Infections will be held virtually from March 6 to March 10, 2021. More information will be released soon. As always, the best and most consequential original research will define the science at virtual CROI 2021, which will include research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. Virtual CROI 2021 will include 4.5 hours per day of live (real-time) interactive and engaging sessions in a variety of formats. In addition, a rich program of on-demand content will be released each day. Live sessions will begin at 10:00 AM Eastern Time (US) each day: Click Here to Convert to Your Local Time.

The CROI 2021 Preliminary Agenda below is under development and will be updated as additional information becomes available.

 

Last Updated: Mar 6, 2021 @ 12:50 pm 

Saturday, March 6, 2021
10:00 AM - 2:00 PM
Eastern Time (USA)
Program Committee Workshop for New Investigators and Trainees

This workshop describes the current state-of-the-art of selected areas of HIV and SARS-CoV-2 basic, epidemiologic, and clinical research being presented at CROI 2021. The workshop is directed toward new investigators (both international and domestic) and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows).

  • Advances in Molecular Virology of HIV and SARS-CoV-2 – Frank Kirchhoff, Ulm University Medical Center, Ulm, Germany
  • Advances in HIV and SARS-CoV-2 Immunology – Galit Alter, Ragon Institute of MGH, Cambridge, MA, USA
  • Advances in COVID-19 Treatments and Controlling the Epidemic – Jürgen Rockstroh, Medizinische Universitatsklini, Bonn, Germany
  • Advances in Biomedical Prevention for HIV and SARS-CoV-2 – Jean-Michel Molina, University of Paris, Paris, France
  • Advances in HIV Cure – Katharine Bar, University of Pennsylvania, Philadelphia, PA, USA
Sunday, March 7, 2021
10:00 AM - 10:15 AM
Eastern Time (USA)
Welcome from the Program Committee Chairs

Welcome and Daily Roadmap

Sharon L. Hillier, University of Pittsburgh, Pittsburgh, PA, USA

10:15 AM - 10:50 AM
Martin Delaney Presentation

Introduction of the Martin Delaney Presentation

James Pickett, AIDS Foundation of Chicago, Chicago, IL, USA

Vaccine Nationalism is Killing Us: How Inequities in Research and Access to SARS-CoV-2 Vaccines Will Perpetuate the Pandemic

  • Gregg Gonsalves, Yale University, New Haven, CT, USA
  • Fatima Hassan, Health Justice Initiative, Cape Town, South Africa
10:50 AM - 11:25 AM
Bernard Fields Lecture

Introduction of the Bernard Fields Lecture

James A. Hoxie, University of Pennsylvania, Philadelphia, PA, USA

Galit Alter, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA

Neutralizing Antibodies Against Coronaviruses

Pamela Bjorkman, California Institute of Technology, Pasadena, CA, USA

11:25 AM - 12:05 PM
N’Galy-Mann Lecture

Introduction of the N’Galy-Mann Lecture

Elaine J. Abrams, ICAP at Columbia University, New York, NY, USA

Lessons from the Concurrent HIV/AIDS and COVID-19 Pandemics: A Two-Way Street
Anthony S. Fauci, National Institutes of Health, Bethesda, MD, USA

12:05 PM - 12:20 PM
Break
12:20 PM – 2:20 PM
Concurrent Technical Workshops

Frontiers in Laboratory Sciences

Conveners

  • Galit Alter, Massachuesetts Institute of Technology and Harvard University, Cambridge, MA, USA
  • Frank Kirchhoff, Ulm University Medical Center, Ulm, Germany

Presenters

  1. Structures of SARS-CoV-2 Antibodies Induced by Infection and mRNA Vaccines – Christopher Barnes, California Institute of Technology, Pasadena, CA, USA
  2. Emerging Concepts in HIV-1 Restriction – Edward Campbell, Loyola University Chicago, Chicago, IL, USA
  3. SARS-CoV-2–Specific and Cross-Reactive T-Cell Responses – Daniela Weiskopf, La Jolla Institute for Immunology, La Jolla, CA, USA
  4. Artificial Intelligence-Inspired Antibody-Engineering – Sai Reddy, Swiss Federal Institute of Technology, Zurich, Switzerland

Clinical Trial Design and Analysis

Conveners

  • Susan P. Buchbinder, San Francisco Department of Public Health, San Francisco, CA, USA
  • Richard E. Chaisson, The Johns Hopkins University, Baltimore, MD, USA

Presenters

  1. Making Sense of Study Design Differences Between COVID-19 Platform Trials – Lori Dodd, National Institutes of Health, Bethesda, MD, USA
  2. Design of Current and Future COVID-19 Vaccine Efficacy Trials – Holly Janes, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Case-Based COVID-19 Clinical Workshop

Conveners

  • Robert T. Schooley, University of California San Diego, La Jolla, CA, USA
  • David L. Thomas, The Johns Hopkins School of Medicine, Baltimore, MD, USA

Presenters

  1. Rapid Genomic Sequencing for Management of COVID-19 – Kwok-Yung Yuen, The University of Hong Kong, Hong Kong
  2. COVID-19: A Hospitalised Unwell Patient with Pneumonitis – Sanjay Bhagani, Royal Free Hospital, London, United Kingdom
  3. Critical Care of COVID-19 – Janhavi Athale, Mayo Clinic Arizona, Phoenix, AZ, USA
Monday, March 8, 2021
10:00 AM - 11:00 AM
Plenary Session

Welcome and Daily Roadmap to virtual CROI 2021

Sharon L. Hillier, University of Pittsburgh, Pittsburgh, PA, USA

Plenary Presentations

Imaging Viral Life Cycles
Hans-Georg Kräusslich, Heidelberg University, Heidelberg, Germany

Disparities in Health: From HIV to COVID-19 and Beyond
James Hildreth, Meharry Medical College, Nashville, TN, USA

11:00 AM - 11:15 AM
Break
11:15 AM - 1:15 PM
Concurrent Oral Abstract Sessions

New abstract-driven research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions.

HIV/SIV Host and Cellular Interactions: Virology, Immunology, and Pathogenesis

Session Moderators

  • John M. Coffin, Tufts University, Medford, MA, USA
  • Richard A. Koup, National Institute of Allergy and Infectious Diseases, Bethesda, MD, US

HIV Treatment and Prevention: New Opportunities to Optimize Drug Dosing, Adherence, and Antiretroviral Therapy

Session Moderators

  • Angela Dawn Marie. Kashuba, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Courtney V. Fletcher, University of Nebraska Medical Center, Omaha, NE, USA

Complications of HIV and COVID-19

Session Moderators

  • Judith S. Currier, University of California Los Angeles, Los Angeles, CA, USA
  • Peter W. Hunt, University of California San Francisco, San Francisco, CA, USA

Identifying Disparities and Opportunities in HIV

Session Moderators

  • Richard E. Chaisson, The Johns Hopkins University, Baltimore, MD, USA
  • Adaora Adimora, The University of North Carolina at Chapel Hill, Chapel Hill, USA
1:15 PM - 1:30 PM
Break
1:30 PM – 2:30 PM
Concurrent Interactive Sessions

Interactive and scientifically fun sessions in a mixture of lively formats such as debates, point-counterpoint discussions, brief talks with expert panel discussions, and “Rapid Fire” sessions: 4 or 5 short (5 mins) presentations by experts in the field.

SARS-CoV-2 Evolution in Populations and Individuals

Moderators

  • Katharine J. Bar, University of Pennsylvania, Philadelphia, PA, USA
  • John Coffin, Tufts University, Boston, MA, USA

Panelists

  1. SARS-CoV-2 and HIV Evolution at the Population Level – Bette Korber, Los Alamos National Laboratory, Los Alamos, NM, USA
  2. SARS-CoV-2 Evolution at the Population Level – Morgane Rolland, Walter Reed Army Institute of Research, Silver Spring, MD, USA
  3. Structure and Function of SARS-CoV-2 Spike Protein Variants – Jeremy Luban, University of Massachusetts, Worcester, MA, USA
  4. Origin and Spread of Highly Transmissible Variants of SARS-CoV-2 – Penny Moore, University of Witwatersrand, Johannesburg, South Africa
  5. Selection of Neutralization Resistant SARS-CoV-2 Mutants – Paul Bieniasz, The Rockefeller University, New York, NY, USA

Case-Based Discussion on Weight Gain in HIV and Antiretroviral Therapy

  • Moderator: Peter Hunt, University of California San Francisco, San Francisco, CA, USA
  • Panelists
    • Grace McComsey, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
    • Sadaf Farooqi, Cambridge University, Cambridge, United Kingdom
    • Jane O’Halloran, Washington University in St Louis, St Louis, MO, USA
    • Cissy Kityo, Joint Clinical Research Centre, Lubowa, Uganda

Contact Tracing in Controlling Epidemics: Is the Juice Worth the Squeeze?

  • Moderator: Wafaa El-Sadr, Columbia University, New York, NY, USA
  • Panelists
    • Chi-Chi Udeagu, New York City Department of Health and Mental Hygiene, New York, NY, USA
    • Matthew Golden, University of Washington, Seattle, WA, USA
    • Jeffrey Kahn, Johns Hopkins University, Baltimore, MD, USA
On-Demand
Science Spotlights

Science Spotlights are a new format for presenting important science that is not part of an oral abstract session. More details are available on the Science Spotlights page

On-Demand
Symposia

Each two-hour symposia includes 4 state-of-the-art talks. Symposia are scheduled on each day of CROI. Speakers are provided 25 minutes to present.

Navigating to the Nucleus

Conveners

  • John M. Coffin, Tufts University, Medford, MA, USA
  • Wesley I. Sundquist, University of Utah School of Medicine, Salt Lake City, UT, USA

Presenters

  1. Live-Cell Imaging: Capsid Trafficking to Nucleus – Barbara Müller, University of Heidelberg, Heidelberg, Germany
  2. Live-Cell Imaging of HIV-1 Nuclear Import, Uncoating, and Proviruses – Vinay Pathak, National Cancer Institute, Frederick, MD, USA
  3. Visualization of HIV-1 Capsid-Dependent Replication In Vitro – Barbie Ganser-Pornillos, University of Virginia, Charlottesville, VA, USA
  4. Lenacapavir (GS-6207): First Clinically Active Long-Acting Inhibitor of HIV Capsid – Tomas Cihlar, Gilead Sciences, Foster City, CA, USA

Innate Immune Defenses Against HIV-1 and SARS-CoV-2 

Conveners

  • Galit Alter, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA
  • Frank Kirchhoff, Ulm University Medical Center, Ulm, Germany

Presenters

  1. Origin, Pathogenicity, and Immune Evasion Strategies of Human Coronaviruses – Volker Thiel, University of Bern, Bern, Switzerland
  2. Immune Evasion of SARS-CoV-2: Nsp1 and Beyond – Konstantin Sparrer, Ulm University, Ulm, Germany
  3. Shared Vulnerabilities and Different Countermeasures of HIV and SARS-CoV-2 – Eric Freed, National Cancer Institute, Frederick, MD, USA
  4. Immune Responses to SARS-CoV-2 – Akiko Iwasaki, Yale University, New Haven, CT, USA

Tuberculosis: New Approaches to Prevention and Treatment and Issues for Pregnant Individuals and Children

Conveners

  • Constance A. Benson, University of California San Diego, San Diego, CA, USA
  • Richard E. Chaisson, The Johns Hopkins University, Baltimore, MD, USA

Presenters

  1. The Potential of Long-Acting Injectable Drugs for Prevention and Treatment of Tuberculous – Eric Nuermberger, Johns Hopkins University, Baltimore, MD, USA
  2. Pregnancy, HIV, and Tuberculosis: Current Pracices and Research Opportunities – Jyoti Mathad, Cornell University, New York, NY, USA
  3. Advances in Pediatric TB Prevention and Treatment – Nicole Salazar-Austin, Johns Hopkins University, Baltimore, MD, USA
  4. Impact of COVID-19 Pandemic on HIV and TB: WHO Perspective – Souyma Swaminathan, World Health Organization, Geneva, Switzerland

Effect of HIV on COVID, Effect of COVID on HIV

Conveners

  • François Dabis, University Bordeaux Segalen, Bordeaux, France
  • Wafaa M. El-Sadr, Columbia University, New York, NY, USA

Presenters

  1. Does HIV Impact COVID-19 Susceptibility or Severity? – Julia del Amo, Ministry of Health, Madrid, Spain
  2. The Impact of COVID-19 on the HIV Pandemic Worldwide – Andrew Kambugu, Infectious Diseases Institute-Makerere University, Kampala, Uganda
  3. The Impact of COVID-19 Beyond HIV – Helen Bygrave, International AIDS Society, Geneva, Switzerland
  4. Fear and COVID-19: Experiences on the Ground – Francois Venter, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
Tuesday, March 9, 2021
10:00 AM - 11:00 AM
Plenary Session

Welcome and Daily Roadmap to virtual CROI 2021

Elaine J. Abrams, ICAP at Columbia University, New York, NY, USA

Plenary Presentations

HIV-1bNAbs: Looking Ahead
Marina Caskey, Rockefeller University, New York, NY, USA

Sustained Delivery and Long-Acting Agents for Prevention of HIV
Linda-Gail Bekker, University of Cape Town, Cape Town, South Africa

11:00 AM - 11:15 AM
Break
11:15 AM - 1:15 PM
Concurrent Oral Abstract Sessions

New abstract-driven research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions.

SARS-CoV-2 vs Host: Virology, Immunology, and Pathogenesis

Session Moderators

  • Wesley I. Sundquist, University of Utah School of Medicine, Salt Lake City, UT, USA
  • Guido Silvestri, Emory University, Atlanta, GA, USA

New Weapons Against SARS-CoV-2 and HIV

Session Moderators

  • Joseph J. Eron, University of North Carolina, Chapel Hill, NC, USA
  • Douglas D. Richman, University of California San Diego, La Jolla, CA, USA

Tuberculous and Hepatitis

Session Moderators

  • Constance A. Benson, University of California San Diego, San Diego, CA, USA
  • Robert T. Schooley, University of California San Diego, La Jolla, CA, USA

COVID Epidemiology and Its Impact on HIV Care and Prevention

Session Moderators

  • Susan P. Buchbinder, San Francisco Department of Public Health, San Francisco, CA, USA
  • James McIntyre, Anova Health Institute, Johannesburg, Gauteng, South Africa

Prevention 2021

Session Moderators

  • Raphael J. Landovitz, University of California Los Angeles, Los Angeles, CA, USA
  • Landon Myer, University of Cape Town, Cape Town, South Africa
1:15 PM - 1:30 PM
Break
1:30 PM – 2:30 PM
Concurrent Interactive Sessions

Interactive and scientifically fun sessions in a mixture of lively formats such as debates, point-counterpoint discussions, brief talks with expert panel discussions, and “Rapid Fire” sessions: 4 or 5 short (5 mins) presentations by experts in the field.

HIV-1 and SARS-CoV-2: Durability of Host Immune Responses from Vaccination or Infection

Moderators

  • Galit Alter, Ragon Institute of MGH, MIT, and Harvard Cambridge, MA, USA
  • Guido Silvestri, Emory University, Atlanta, GA, USA

Panelists

  1. Humoral Responses Against the SARS-CoV-2 Spike – Andrés Finzi, University of Montreal, Montreal, Canada
  2. T-Cell Immunity in SARS-CoV-2 Natural Infection and Following Vaccination – Julie McElrath, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  3. Longitudinal Antibody Responses to SARS-CoV-2 and Emerging Variants – Katie Doores, King’s College London, London, United Kingdom
  4. Programming Durable Immunity – Robert Seder, Vaccine Research Center, Bethesda, MD USA
  5. Pathological B-Cell activation During SARS-CoV-2 Infection – Ignacio Sanz, Emory University, Atlanta, GA, USA

From Daily Pills to Monthly Shots for HIV Prevention and Treatment: Can Efficacy Be Translated into Effectiveness?

  • Moderators
    • Carlos del Rio, Emory University, Atlanta, GA, USA
    • Diane Havlir, University of California San Francisco, San Francisco, CA, USA
  • Panelists
    • Francois Venter, Ezintsha School of Clinical Medicine, Johannesburg, South Africa
    • Nittaya Phanuphak, Institute of HIV Research and Innovation, Bangkok, Thailand
    • Charles Flexner, The Johns Hopkins University, Baltimore, MD, USA
    • Hyman Scott, San Francisco Department of Public Health, San Francisco, CA. USA

PrEP Scale-Up to Meet UNAIDS 2030 Goals: Is it Possible?

  • Moderator: Sheena McCormack, University College London, London, United Kingdom
  • Panelists
    • Elizabeth Irungu, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya
    • Mark Dybul, Georgetown University, Washington, DC, USA
On-Demand
Science Spotlights

Science Spotlights are a new format for presenting important science that is not part of an oral abstract session. More details are available on the Science Spotlights page

On-Demand
Symposia

Each two-hour symposia includes 4 state-of-the-art talks. Symposia are scheduled on each day of CROI. Speakers are provided 25 minutes to present.

Immune-Mediating Killing of HIV Reservoirs: Opportunities and Obstacles

Conveners

  • Nicolas Chomont, Université de Montréal, Montreal, Quebec, Canada
  • Katharine J. Bar, University of Pennsylvania, Philadelphia, PA, USA

Presenters

  1. How to Generate Good Killers by Initiating ART (Not Too) Early? – Lydie Trautmann, Oregon Health Sciences University, Portland, OR, USA
  2. Breaking the B-Cell Barrier to Eliminate Viral Reservoirs – Afam Okoye, Oregon Health Sciences University, Portland, OR, USA
  3. Intrinsic Resistance of Reservoir Cells to Immune Killing – R. Brad Jones, Weill Cornell Medicine, New York, NY, USA
  4. Type I Interferon Resistance of Rebound HIV-1 – Beatrice Hahn, University of Pennsylvania, Philadelphia, PA, USA

Novel Antiviral Strategies and How to Deploy Them

Conveners

  • Joseph J. Eron, University of North Carolina, Chapel Hill, NC, USA
  • Huldrych F. Günthard, University Hospital Zurich, Zurich, Switzerland

Presenters

  1. Triple-Drug ART, Dual ART, or Just ART? – Jose Arribas, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
  2. Novel Antiretroviral Therapies in Clinical Development – Alexandra Calmy, University Hospital Geneva, Geneva, Switzerland
  3. ARVs and ART for Newborns and Infants: A Last Frontier – Moherndren Archary, University of KwaZulu-Natal, Durban, South Africa
  4. Got Anything for This Cough? New Antivirals for Treatment of SARS-CoV-2 – Davey Smith, University of California San Diego, San Diego, CA, USA

COVID-19: Far More Than Just the Lungs

Conveners

  • Serena S. Spudich, Yale University, New Haven, CT, USA
  • Peter Reiss, Amsterdam University Medical Centers, Amsterdam, Netherlands

Presenters

  1. Single Vascular Cell Heterogeneity in Health and Disease: A COVID-19 Update – Peter Carmeliet, University of Leuven, Leuven, Belgium
  2. Body on Fire: Multisystem Inflammatory Syndrome in Children – Elizabeth Whittaker, Imperial College London, London, United Kingdom
  3. Think About It: Neurologic Manifestations of COVID-19 – Benedict Michael, University of Liverpool, Liverpool United Kingdom
  4. COVID-19: Concerns of the Heart – Valentina Puntmann, Goethe University, Frankfurt, Germany

What does PrEP Deliver?

Conveners

  • Connie L. Celum, University of Washington, Seattle, WA, USA
  • Monica Gandhi, University of California San Francisco, San Francisco, CA, USA

Presenters

  1. Young Women: Adherence, Effect, and Retention – Thesla Palanee-Phillips, Wits Reproductive Health and HIV Institute, Johannes, South Africa
  2. Challenges and Opportunities in Implementing PrEP in Key Populations – Gregorio Millett, amFAR, Washington, DC, USA
  3. Models of Delivering PrEP in East Africa: Innovations and Lessons Learned – Moses Kamya, Makerere University College of Health Sciences, Kampala, Uganda
  4. Incorporating Injectable PrEP and Newer Formulations into LMIC – Yogan Pillay, Clinton Health Access Initiative, South Africa
Wednesday, March 10, 2021
10:00 AM - 11:00 AM
Eastern Time (USA)
Plenary Session

Welcome and Daily Roadmap to virtual CROI 2021

James Hoxie, University of Pennsylvania, Philadelphia, PA, USA

Plenary Presentations

Elite Controllers: A Model for a Functional Cure of HIV-1 Infection
Xu Yu, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA

HIV Treatment in Pregnancy: Beyond Prevention of Vertical Transmission
Shahin Lockman, Brigham and Women’s Hospital, Boston, MA, USA

11:00 AM - 11:15 AM
Break
11:15 AM - 1:15 PM
Concurrent Oral Abstract Sessions

New abstract-driven research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions.

HIV Reservoirs

Session Moderators

  • Douglas D. Richman, University of California San Diego, La Jolla, CA, USA
  • Katharine J. Bar, University of Pennsylvania, Philadelphia, PA, USA

Brain Connections, Malignancies, and Tumor Viruses

Session Moderators

  • Dennis L. Kolson, University of Pennsylvania, Philadelphia, PA, USA
  • Ronald Mitsuyasu, University of California Los Angeles, Los Angeles, CA, USA

Maternal and Child HIV and SARS-CoV-2

Session Moderators

  • Landon Myer, University of Cape Town, Cape Town, South Africa
  • Hermione Lyall, Imperial College Healthcare National Health Service Trust, London, London, United Kingdom

Innovations and Challenges in Testing, Prevention, and Care

Session Moderators

  • Jonathan Mermin, Centers for Disease Control and Prevention, Atlanta, GA, USA

Wafaa M. El-Sadr, Columbia University, New York, NY, USA

1:15 PM - 1:30 PM
Break
1:30 PM – 2:30 PM
Concurrent Interactive Sessions

Interactive and scientifically fun sessions in a mixture of lively formats such as debates, point-counterpoint discussions, brief talks with expert panel discussions, and “Rapid Fire” sessions: 4 or 5 short (5 mins) presentations by experts in the field.

SARS-CoV-2 and the Host Immune Response: Good vs Bad Immunity

Moderators

  • Richard A. Koup, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
  • Nicolas Chomont, Université de Montréal, Montreal, Canada

Panelists

  1. SARS-CoV-2 Debris and Its Contribution to COVID-19 – Benjamin tenOever, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  2. Toward Sweet Therapies for Sour Immunopathologies in COVID-19 – Catherine Blish, Stanford University School of Medicine, Stanford, CA, USA
  3. Afucosylated IgG Responses and Severity in COVID-19 – Gestur Vidarsson, University of Amsterdam, Amsterdam, Netherlands
  4. Anticipating Escape Pathways for SARS-CoV-2 – Julie Overbaugh, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  5. The Spectrum of T-Cell Responses to SARS-CoV-2 – Markus Buggert, Karolinska Institutet, Stockholm, Sweden

COVID-19 Clinical Controversies

  • Case Presenters
    • Roy Gulick, Weill Cornell Medical College, New York, NY, USA
    • Paul Sax, Brigham and Women’s Hospital, Boston, MA, USA
  • Panelists
    • Karine Lacombe, Saint-Antoine Hospital, Paris, France
    • Claudia Cortes, University of Chile, Santiago, Chile
    • Zarir Udwadia, Hinduja Hospital and Medical Research Center, Mumbai, India

COVID Disparities: How Can They Help Move the Needle Forward?

Moderators

  • Adaora Adimora, University of North Carolina at Chapel, Hill, Chapel Hill, NC, USA
  • Monica Gandhi, University of California San Francisco, San Francisco, CA, USA

Panelists

  1. Disparities in COVID-19 Among Racial and Ethnic Minorities in the US – Mary Bassett, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  2. Disparities in COVID-19 in Native American Communities – David Wilson, National Institutes of Health, Bethesda, MD, USA
  3. Incarcerated Populations and COVID-19 – Robert Fullilove, Columbia University Medical Center, New York, NY, USA
On-Demand
Science Spotlights

Science Spotlights are a new format for presenting important science that is not part of an oral abstract session. More details are available on the Science Spotlights page

On-Demand
Symposia

Each two-hour symposia includes 4 state-of-the-art talks. Symposia are scheduled on each day of CROI. Speakers are provided 25 minutes to present.

New Findings and Unsettled Controversies in Central Nervous System Infection and Disease

Conveners

  • Dennis L. Kolson, University of Pennsylvania, Philadelphia, PA, USA
  • Serena S. Spudich, Yale University, New Haven, CT, USA

Presenters

  1. Novel Findings of Neuronal Modulation of HIV Expression in Microglia – Jonathan Karn, Case Western Reserve University, Cleveland, OH, USA
  2. Role of CNS CD4 T Cells and Macrophages in Neuropathogenesis and Reservoirs – Vanessa Hirsch, National Institutes of Health, Bethesda, MD, USA
  3. Impact of Myeloid Reservoirs in HIV Cure Trials – Lishomwa Ndhlovu, Weill Cornell Medicine, New York, NY, USA
  4. Lessons from CNS HIV Escape and ATI for Understanding HIV Persistence in the CNS – Sarah Joseph, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Adolescents, Youth, and PrEP

Conveners

  • Annette H. Sohn, Therapeutics Research Education and AIDS Training in Asia, Bangkok, Thailand
  • Connie L. Celum, University of Washington, Seattle, WA, USA

Presenters

  1. PrEP During Pregnancy and Breastfeeding – John Kinuthia, University of Nairobi, Nairobi, Kenya
  2. Improving Adolescent PrEP Use: Understanding Developmental Processes and Context – Claude Mellins, Columbia University, New York, NY, USA
  3. PrEP Adherence Interventions for Adolescents and Young Adults – Sybil Hosek, Stroger Hospital, Chicago, IL, USA
  4. Improving How we Market PrEP to Youth – Elzette Rousseau, University of Cape Town, Cape Town, South Africa

Focus on the Liver: New Insights Into Management and Control of Liver Disease

Conveners

  • David L. Thomas, The Johns Hopkins School of Medicine, Baltimore, MD, USA
  • Jürgen K. Rockstroh, Medizinische Universitatsklini, Bonn, Germany

Presenters

  1. Hepatitis C Elimination: What’s Taking So Long? – Annie Luetkemeyer, University of California San Francisco, San Francisco, CA, USA
  2. Mechanisms and Treatments of Steatosis in HIV – Steve Grinspoon, Harvard Medical School, Boston, MA, USA
  3. Harnessing Immunity To Cure HBV – Ulrike Protzer, Technische Universität München, Munich, Germany
  4. New Prospects for the Treatment of HBV – Heiner Wedemeyer, Hannover Medical School, Hannover, Germany

COVID-19 Vaccine: From Efficacy to Effectiveness

Conveners

  • Susan P. Buchbinder, San Francisco Department of Public Health, San Francisco, CA, USA
  • Carlos del Rio, Emory University, Atlanta, GA, USA

Presenters

  1. Lessons Learned and Challenges in COVID-19 Vaccine Trials – Kathy Neuzil, University of Maryland, Baltimore, MD, USA
  2. Equitable Roll-Out of COVID-19 Vaccines in the United States – Michelle Williams, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  3. Vaccine Hesitancy – Saad Omer, Yale University, New Haven, CT, USA
  4. Global Distribution of the SARS-CoV-2 Vaccine – Nicole Lurie, Coalition for Epidemic Preparedness Innovations, Washington, DC, USA